Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511368
Status:
COMPLETED
Last Update Posted:
2010-01-20
First Post:
2007-08-01
Brief Title:
Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks
Sponsor:
Myrexis Inc
Organization:
Myrexis Inc
Organization Data
Organization:
Myrexis Inc
Class:
INDUSTRY
Study ID:
PA103001-04 Study 203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Myrexis Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Andrew Beelen MD Sr Director Clinical Research
Old Organization:
Myriad Pharmaceuticals